Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled Study of Memantine as an Adjunct to Naltrexone in the Treatment of Opioid Dependence

NCT00476242 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00476242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00476242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled Study of Memantine as an Adjunct to Naltrexone in the Treatment of Opioid Dependence
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2011
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heroin dependence, opioid dependence